NovaBridge Biosciences (NBP) Financial Statements

427 Followers

NovaBridge Biosciences Financial Overview

NovaBridge Biosciences's market cap is currently $203.07M. The company's EPS TTM is $-0.5988; its P/E ratio is -25.05; NovaBridge Biosciences is scheduled to report earnings on May 14, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Dec 23	Mar 23	Dec 21
Income Statement
Total Revenue	¥ 0.00	¥ 0.00	¥ 4.49M	¥ -10.70M	¥ 88.03M
Gross Profit	¥ 0.00	¥ 0.00	¥ 4.49M	¥ -248.80M	¥ 41.59M
Operating Income	¥ -13.48M	¥ -375.36M	¥ -511.16M	¥ -366.08M	¥ -2.07B
EBITDA	¥ -13.35M	¥ -373.45M	¥ -344.25M	¥ -51.23M	¥ -2.06B
Net Income	¥ -6.61M	¥ -162.26M	¥ -1.47B	¥ -2.51B	¥ -2.33B
Balance Sheet
Cash & Short-Term Investments	¥ 30.14M	¥ 173.40M	¥ 311.73M	¥ 3.45B	¥ 670.96M
Total Assets	¥ 37.24M	¥ 212.68M	¥ 368.92M	¥ 4.07B	¥ 878.74M
Total Debt	¥ 438.46K	¥ 3.88M	¥ 3.89M	¥ 38.29M	¥ 17.64M
Net Debt	¥ -29.67M	¥ -64.38M	¥ -287.62M	¥ -3.18B	¥ -535.16M
Total Liabilities	¥ 4.23M	¥ 11.52M	¥ 126.34M	¥ 1.07B	¥ 163.42M
Stockholders' Equity	¥ 33.02M	¥ 201.16M	¥ 242.58M	¥ 3.01B	¥ 715.33M
Cash Flow
Free Cash Flow	¥ -20.60M	¥ -52.72M	¥ -73.02M	¥ -1.15B	¥ -1.00B
Operating Cash Flow	¥ -20.60M	¥ -52.67M	¥ -72.85M	¥ -1.10B	¥ -973.09M
Investing Cash Flow	¥ 104.97M	¥ -135.97M	¥ -107.63M	¥ 458.38M	¥ -727.21M
Financing Cash Flow	¥ 57.73M	¥ -334.89K	¥ -8.25M	¥ 42.36M	¥ 593.92M

Currency in CNY

NovaBridge Biosciences Earnings and Revenue History

Income Statement >

NovaBridge Biosciences Debt to Assets

Balance Sheet >

NovaBridge Biosciences Cash Flow

Cash Flow >

NovaBridge Biosciences Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >